FrancophonIA/ELRC3.0 huggingface dataset:
English: - Genotypic resistance to efavirenz, predominantly the K103N mutation, developed in virus from 13/19 (68%) patients in the emtricitabine/tenofovir disoproxil /efavirenz group and in virus from 21/29 (72%) patients in the comparative group.
Danish: Genotyperesistens over for efavirenz, især K103N-mutationen, udviklede sig i virus fra 13/19 (68%) af patienterne i emtricitabin/tenofovirdisoproxil/efavirenz-gruppen og i virus fra 21/29 (72%) af patienterne i sammenligningsgruppen.
English: should preferably be taken with food.
Danish: skal helst tages sammen med mad.
English: renal failure (acute and chronic), acute tubular necrosis, nephritis (including acute interstitial nephritis)
Danish: tubulær nekrose, nefritis (herunder akut interstitiel nefritis)
English: Summary of Product Characteristics and an appropriate educational brochure, as detailed below:
Danish: er forsynet med en undervisningspakke for læger, der indeholder produktresuméet og en passende undervisningsbrochure som beskrevet nedenfor:
English: The Marketing Authorisation Holder (MAH) shall ensure that all physicians who are expected to prescribe/use Emtricitabine/Tenofovir disoproxil Krka d.d.
Danish: Indehaveren af markedsføringstilladelsen skal sikre, at alle læger, som forventes at ordinere/anvende Emtricitabine/Tenofovir disoproxil Krka d.d.
English: In a randomised clinical study (M02-418), 190 antiretroviral-naïve adults were treated once daily with emtricitabine and tenofovir disoproxil in combination with lopinavir/ritonavir given once or twice daily.
Danish: I et randomiseret, klinisk studie (M02-418) blev 190 antiretroviral-naive voksne behandlet en gang daglig med emtricitabin og tenofovirdisoproxil i kombination med lopinavir/ritonavir adminisreret en eller to gange daglig.
English: Deutschland TAD Pharma GmbH Tel: + 49 (0) 4721 606-0
Danish: TAD Pharma GmbH Tel: + 49 (0) 4721 606-0
English: film coated tablets are blue, oval, biconvex tablets, of dimensions 20 mm x 10 mm.
Danish: filmovertrukne tabletter er blå, ovale, bikonvekse tabletter, der måler 20 mm × 10 mm.
English: film coated tablets (tablets) are blue, oval, biconvex tablets, of dimensions 20 mm x 10 mm.
Danish: filmovertrukne tabletter (tabletter) er blå, ovale, bikonvekse tabletter, der måler 20 mm x 10 mm.
English: Know your hepatitis B virus (HBV) infection status before starting Emtricitabine/Tenofovir disoproxil Krka d.d..
Danish: Kend Deres status for hepatitis B virus (HBV)-infektion inden De begynder at tage Emtricitabine/Tenofovir disoproxil Krka d.d..
English: should be avoided in antiretroviral-experienced patients with HIV-1 harbouring the K65R mutation (see section 5.1).
Danish: bør undgås hos tidligere antiretroviral-erfarne patienter med hiv 1, som har K65R-mutationen (se pkt.
English: If you become pregnant, or plan to become pregnant, ask your doctor about the potential benefits and risks of therapy with Emtricitabine/Tenofovir disoproxil Krka d.d.
Danish: Hvis De bliver gravid eller planlægger at blive gravid, skal De kontakte Deres læge for at drøfte de potentielle fordele og risici, som behandling med Emtricitabine/Tenofovir disoproxil Krka d.d.
English: In order to optimise the absorption of tenofovir, it is recommended that Emtricitabine/Tenofovir disoproxil Krka d.d.
Danish: For at optimere tenofovirs absorption anbefales det, at Emtricitabine/Tenofovir disoproxil Krka d.d.
English: The following may be signs of lactic acidosis: deep rapid breathing drowsiness feeling sick (nausea), being sick (vomiting) stomach pain → If you think you may have lactic acidosis, get medical help immediately.
Danish: Følgende kan være tegn på laktatacidose: dyb, hurtig vejrtrækning døsighed kvalme, opkastning mavesmerter → Hvis De tror, De har laktatacidose, skal De straks søge læge.
English: with other medicines containing didanosine (for treatment of HIV infection): Taking Emtricitabine/Tenofovir disoproxil Krka d.d.
Danish: sammen med medicin som indeholder didanosin (til behandling af hiv-infektion): Hvis De tager Emtricitabine/Tenofovir disoproxil Krka d.d.
English: In addition, the clinical response to treatment should be closely monitored in patients receiving Emtricitabine/Tenofovir disoproxil Krka d.d.
Danish: Det kliniske respons på behandlingen bør endvidere monitoreres nøje hos patienter, der får Emtricitabine/Tenofovir disoproxil Krka d.d.
English: Based on minimal hepatic metabolism and the renal route of elimination for emtricitabine, it is unlikely that a dose adjustment would be required for Emtricitabine/Tenofovir disoproxil Krka d.d.
Danish: På grund af minimal hepatisk metabolisme og den renale eliminationsvej for emtricitabin er det usandsynligt, at dosisjustering af Emtricitabine/Tenofovir disoproxil Krka d.d.
English: 30 film-coated tablets: EU/1/17/1182/002 90 (3 x 30) film-coated tablets: EU/1/17/1182/004
Danish: 30 filmovertrukne tabletter: EU/1/17/1182/002 90 (3 x 30) filmovertrukne tabletter: EU/1/17/1182/004
English: Film coating: hypromellose 5 cP, titanum dioxide (E171), macrogol, indigo carmine aluminium lake (E132).
Danish: mikrokrystallinsk cellulose, natriumstearylfumarat, stearinsyre Overtræk: hypromellose 5 cP, titandioxid (E171), macrogol, indigocarmin aluminiumpigment (E132).
English: (see sections 4.2, 4.4 and 5.2).
Danish: 4.2, 4.4 og 5.2).
English: The safety and efficacy of emtricitabine/tenofovir disoproxil in children under the age of 12 years have not been established.
Danish: Sikkerheden og virkningen af emtricitabine/tenofovir hos børn under 12 år er ikke klarlagt.
English: 200 mg/245 mg film-coated tablets emtricitabine/tenofovir disoproxil
Danish: 200 mg/245 mg filmovertrukne tabletter emtricitabinum/tenofovirum disoproxilum
English: without contacting your doctor.
Danish: uden først at konsultere Deres læge.
English: Late onset neurological disorders have been reported rarely (hypertonia, convulsion, abnormal behaviour).
Danish: Sent forekommende neurologiske forstyrrelser er i sjældne tilfælde blevet rapporteret (hypertoni, kramper,
English: As of week 144: - The M184V/I mutation developed in 2/19 (10.5%) isolates analysed from patients in the emtricitabine/tenofovir disoproxil /efavirenz group and in 10/29 (34.5%) isolates analysed from the lamivudine/zidovudine/efavirenz group (p-value < 0.05, Fisher's Exact test comparing the emtricitabine+tenofovir disoproxil group to the lamivudine/zidovudine group among all patients).
Danish: M184V/I-mutationen udviklede sig hos 2/19 (10,5%) af de isolater, der blev analyseret fra patienter i emtricitabin/tenofovirdisoproxil/efavirenz-gruppen og hos 10/29 (34,5%) af de isolater, der blev analyseret fra lamivudin/zidovudin/efavirenz-gruppen (p-værdi < 0,05 Fisher's Exact test, her sammenligning af alle patienterne fra henholdsvis emtricitabin+tenofovirdisoproxil-gruppen med lamivudin/zidovudin-gruppen).
English: is available in carton boxes of 28 and 84 film-coated tablets in blisters.
Danish: fås i æsker med 28 og 84 filmovertrukne tabletter i blisterpakninger.
English: Limited pharmacokinetic data are available for emtricitabine and tenofovir after co-administration of separate preparations or as emtricitabine/tenofovir disoproxil in patients with renal impairment.
Danish: Der foreligger begrænsede farmakokinetiske data for emtricitabin og tenofovir efter samtidig administration i form af separate præparater eller i form af emtricitabin/tenofovirdisoproxil hos patienter med nedsat nyrefunktion.
English: If you have HBV, there is a serious risk of liver problems when you stop taking Emtricitabine/Tenofovir disoproxil Krka d.d., whether or not you also have HIV.
Danish: Hvis De har hepatitis B, er der en alvorlig risiko for at få leverproblemer, når De holder op med at tage Emtricitabine/Tenofovir disoproxil Krka d.d., uanset om De også har hiv.
English: Individuals with renal impairment: Since tenofovir disoproxil can cause renal toxicity, close monitoring of renal function is recommended in any adults with renal impairment receiving Emtricitabine/Tenofovir disoproxil Krka d.d.
Danish: Personer med nedsat nyrefunktion: Da tenofovirdisoproxil kan forårsage nefrotoksicitet, anbefales tæt monitorering af nyrefunktionen hos alle voksne med nedsat nyrefunktion, som får Emtricitabine/Tenofovir disoproxil Krka d.d.
English: is used with nephrotoxic medicinal products, renal function should be closely monitored according to the recommended schedule - That paediatric patients should have their baseline renal function assessed prior to initiating Emtricitabine/Tenofovir disoproxil Krka d.d.
Danish: anvendes sammen med nefrotoksiske lægemidler, skal nyrefunktionen monitoreres omhyggeligt i overensstemmelse med den anbefalede tidsplan - At pædiatriske patienters nyrefunktion skal vurderes, før Emtricitabine/Tenofovir disoproxil Krka d.d.
English: Individuals over the age of 65 years are more likely to have decreased renal function, therefore caution should be exercised when administering Emtricitabine/Tenofovir disoproxil Krka d.d.
Danish: Da det er mere sandsynligt, at personer over 65 år har nedsat nyrefunktion, skal der udvises forsigtighed ved administration af Emtricitabine/Tenofovir disoproxil Krka d.d.
English: Separate preparations of emtricitabine and tenofovir disoproxil are available for treatment of HIV-1 infection if it becomes necessary to discontinue or modify the dose of one of the components of Emtricitabine/Tenofovir disoproxil Krka d.d..
Danish: Der findes separate præparater med emtricitabin og tenofovirdisoproxil til behandling af hiv 1infektion, hvis det bliver nødvendigt at seponere eller ændre dosen af ét af Emtricitabine/Tenofovir disoproxil Krka d.d.
English: If you have hepatitis B, it is especially important not to stop your Emtricitabine/Tenofovir disoproxil Krka d.d.
Danish: Hvis De har hepatitis B, er det særlig vigtigt ikke at ophøre med behandlingen med Emtricitabine/Tenofovir disoproxil Krka d.d.
English: You do not need to take another tablet if you were sick more than 1 hour after taking Emtricitabine/Tenofovir disoproxil Krka d.d..
Danish: De behøver ikke tage en ny tablet, hvis De kastede op mere end en time efter, De tog Emtricitabine/Tenofovir disoproxil Krka d.d.
English: therapy - Recommended schedule for monitoring renal function considering the presence or absence of additional risk factors for renal impairment - That if serum phosphate is confirmed to be < 3.0 mg/dl (0.96 mmol/l) in any paediatric patient receiving tenofovir disoproxil, renal function should be re-evaluated within one week.
Danish: -behandling - Anbefalet tidsplan for monitorering af nyrefunktionen under hensyntagen til forekomst eller fravær af yderligere risikofaktorer for nedsat nyrefunktion - At nyrefunktionen revurderes inden for en uge, hvis serumphosphat bekræftes at være < 3,0 mg/dl (0,96 mmol/l) hos enhver pædiatrisk patient, der får tenofovirdisoproxil.
English: contains two active substances, emtricitabine and tenofovir disoproxil.
Danish: indeholder to aktive stoffer, emtricitabin og tenofovirdisoproxil.
English: A multidisciplinary approach is recommended to weigh the benefit/risk balance of the use of emtricitabine/tenofovir, decide the appropriate monitoring during treatment (including decision for treatment withdrawal) and consider the need for supplementation on a case by case basis.
Danish: Multidisciplinær tilgang anbefales for at opnå af afveje benefit/risk-forholdet ved brugen af emtricitabine/tenofovir, for at kunne træffe afgørelse om relevant monitorering under behandlingen
English: (emtricitabine 200 mg, tenofovir disoproxil 245 mg)
Danish: (emtricitabin 200 mg, tenofovirdisoproxil 245 mg)
English: should not be used during breast-feeding.
Danish: bør derfor ikke anvendes under amning.
English: There are uncertainties associated with the long-term renal and bone effects of tenofovir disoproxilduring the treatment of HIV-1 infection in the paediatric population.
Danish: Der er usikkerhed om langtidsvirkningen af tenofovirdisoproxil toksiske virkninger på nyrer og knogler under behandling af HIV 1-infektion hos den pædiatriske population.
English: In patients who received treatment with tenofovir disoproxil, or stavudine or zidovudine, mean lumbar spine BMD Z score was -1.034 and0.498, and mean total body BMD Z-score was -0.471 and -0.386, respectively, at baseline.
Danish: Hos patienter, der fik behandling med tenofovirdisoproxil, eller stavudin eller zidovudin, var den gennemsnitlige BMD Z-score i lænderygsøjlen -1,034 og -0,498, og den gennemsnitlige BMD Z-score i hele kroppen var henholdsvis -0,471 og -0,386 ved baseline.
English: should be taken as soon as possible and the normal dosing schedule should be resumed.
Danish: sammen med mad så snart som muligt og derefter fortsætte i henhold til den normale doseringsplan.
English: Tests may also show: decreases in phosphate in the blood increased creatine kinase
Danish: nedsat indhold af i phosphat i blodet forhøjet kreatinkinase
English: Cmin: NC
Danish: Cmin: IB
English: If serum phosphate is confirmed to be < 3.0 mg/dl (0.96 mmol/l) in any paediatric patient receiving Emtricitabine/Tenofovir disoproxil Krka d.d., renal function should be re-evaluated within one week, including measurements of blood glucose, blood potassium and urine glucose concentrations (see section 4.8, proximal tubulopathy).
Danish: Hvis serumphosphat bekræftes at være < 3,0 mg/dl (0,96 mmol/l) hos en pædiatrisk patient, der får Emtricitabine/Tenofovir disoproxil Krka, skal nyrefunktionen revurderes inden for en uge, herunder måling af blodglucose, blodkalium og uringlucose (se pkt.
English: contains - The active substances are emtricitabine and tenofovir disoproxil.
Danish: indeholder - De aktive stoffer er emtricitabin og tenofovirdisoproxil.
English: associated changes in BMD on long term bone health and future fracture risk are currently unknown in paediatric patients - That if bone abnormalities are detected or suspected then consultation with an endocrinologist and/or nephrologist should be obtained
Danish: kan give anledning til et fald i BMD, og at indvirkningen på knoglesundheden på langt sigt og på den fremtidige frakturrisiko af de ændringer i BMD, der forbindes med Emtricitabine/Tenofovir disoproxil Krka d.d., p.t. ikke er kendt hos pædiatriske patienter - At der bør søges råd hos en endokrinolog og/eller en nefrolog, hvis knogleabnormiteter mistænkes eller påvises hos pædiatriske patienter
English: Therefore, the same problems may be seen if Emtricitabine/Tenofovir disoproxil Krka d.d.
Danish: De samme problemer kan derfor muligvis optræde, hvis Emtricitabine/Tenofovir disoproxil Krka d.d.
English: - HIV pediatric renal educational brochure
Danish: - Undervisningsbrochure om HIV og nyrefunktion hos pædiatriske patienter
English: Patients receiving ledipasvir/sofosbuvir, sofosbuvir/velpatasvir or sofosbuvir/velpatasvir/voxilaprevir concomitantly with tenofovir disoproxil and a boosted HIV protease inhibitor should be monitored for adverse reactions related to tenofovir disoproxil.
Danish: Patienter, der får ledipasvir/sofosbuvir, sofosbuvir/velpatasvir eller sofosbuvir/velpatasvir/voxilaprevir sammen med tenofovirdisoproxil og en boostet hiv-proteasehæmmer, bør overvåges for bivirkninger relateret til tenofovirdisoproxil.
English: Talk to your doctor if you are intolerant to lactose (see Emtricitabine/Tenofovir disoproxil Krka d.d.
Danish: Tal med Deres læge, hvis De ikke kan tåle lactose (se ”Emtricitabine/Tenofovir disoproxil Krka d.d.
English: should be avoided with concurrent or recent use of a nephrotoxic medicinal product (see section 4.5).
Danish: bør undgås ved samtidig eller nylig brug af et nefrotoksisk lægemiddel (se pkt.
English: A decreased dosage of 250 mg didanosine coadministered with tenofovir disoproxil therapy has been associated with reports of high rates of virological failure within several tested combinations for the treatment of HIV-1 infection.
Danish: I forbindelse med en reduceret dosis på 250 mg didanosin administreret samtidig med tenofovirdisoproxil er der blevet rapporteret om en høj forekomst af manglende virologisk virking af flere testede kombinationer til behandling af hiv 1-infektion.
English: should not be administered concomitantly with other medicinal products containing emtricitabine, tenofovir disoproxil, tenofovir alafenamide or other cytidine analogues, such as lamivudine (see section 4.4).
Danish: bør ikke administreres sammen med andre lægemidler, som indeholder emtricitabin, tenofovirdisoproxil, tenofoviralafenamid eller andre cytidinanaloger, såsom lamivudin (se pkt.
English: If you notice 12 hours or more after the time you usually take Emtricitabine/Tenofovir disoproxil Krka d.d., forget about the missed dose.
Danish: Hvis De kommer i tanke om en glemt dosis 12 timer eller mere efter det tidspunkt, hvor De normalt tager Emtricitabine/Tenofovir disoproxil Krka d.d., skal De ikke tage den glemte dosis.
English: If you notice within 12 hours of the time you usually take Emtricitabine/Tenofovir disoproxil Krka d.d., take the tablet preferably with food as soon as possible.
Danish: Hvis De kommer i tanke om en glemt dosis inden for 12 timer efter det tidspunkt, hvor De normalt tager Emtricitabine/Tenofovir disoproxil Krka d.d., er det bedst, at De tager tabletten med mad så hurtigt som muligt.
English: and didanosine is not recommended (see section 4.4 and Table 2).
Danish: og didanosin kan ikke anbefales (se pkt.
English: Use with ledipasvir and sofosbuvir, sofosbuvir and velpatasvir or sofosbuvir, velpatasvir and voxilaprevir
Danish: Brug med ledipasvir og sofosbuvir,sofosbuvir og velpatasvir eller sofosbuvir, velpatasvir og voxilaprevir
English: Use of tenofovir disoproxil may cause a reduction in BMD.
Danish: Indvirkning på knogler brug af tenofovirdisoproxil kan forårsage et fald i knoglemineraltæthed (BMD).
English: is also indicated for the treatment of HIV-1 infected adolescents, with NRTI resistance or toxicities precluding the use of first line agents (see section 4.2, 4.4 and 5.1).
Danish: er også indiceret til behandling af HIV 1-inficerede unge med NRTI-resistens eller -toksicitet, der udelukker brug af førstevalgspræparater (se pkt.
English: may cause renal damage monitoring of renal function is recommended (see section 4.4).
Danish: kan foråsage nyreskader, anbefales monitorering af nyrefunktionen (se pkt.
English: If vomiting occurs within 1 hour of taking Emtricitabine/Tenofovir disoproxil Krka d.d., another tablet should be taken.
Danish: Hvis patienten kaster op inden for 1 time efter at have taget Emtricitabine/Tenofovir disoproxil Krka d.d., skal der tages en ny tablet.
English: In an open-label randomised clinical study (GS-01-934), antiretroviral-naïve HIV-1 infected adult patients received either a once daily regimen of emtricitabine, tenofovir disoproxil and efavirenz (n = 255) or a fixed combination of lamivudine and zidovudineadministered twice daily and efavirenz once daily (n = 254).
Danish: I et åbent, randomiseret, klinisk studie (GS-01-934) fik antiretroviral-naive voksne patienter inficeret med hiv-1 et regime med enten emtricitabin, tenofovirdisoproxil og efavirenz en gang daglig (n = 255)
English: Antimycobacterials Rifampicin/Tenofovir disoproxil
Danish: Antimykobakterielle midler Rifampicin/Tenofovirdisoproxil
English: is not recommended in individuals under the age 18 years with renal impairment (see section 4.2).
Danish: frarådes hos personer under 18 år med nedsat nyrefunktion (se pkt.
English: Treatment of HIV-1 infection in the paediatric population There are no clinical studies conducted with emtricitabine/tenofovir disproxil in the paediatric population with HIV-1 infection.
Danish: Der er ikke udført kliniske studier med emtricitabine/tenofovirdisoproxil hos den pædiatriske population med HIV 1-infektion.
English: It is important not to stop taking Emtricitabine/Tenofovir disoproxil Krka d.d.
Danish: Det er vigtigt, at De ikke holder op med at tage Emtricitabine/Tenofovir disoproxil Krka d.d.
English: Therefore, a careful benefitrisk assessment is needed when Emtricitabine/Tenofovir disoproxil Krka d.d.
Danish: Det er derfor nødvendigt nøje at vurdere fordele og risici, når Emtricitabine/Tenofovir disoproxil Krka d.d.
English: The safety of tenofovir disoproxil when co-administered with ledipasvir/sofosbuvir, sofosbuvir/velpatasvir or sofosbuvir/velpatasvir/voxilaprevir and a pharmacokinetic enhancer has not been established.
Danish: Sikkerheden af tenofovirdisoproxil ved administration sammen med ledipasvir/sofosbuvir, sofosbuvir/velpatasvir eller sofosbuvir/velpatasvir/voxilaprevir og en farmakokinetisk forstærker er ikke klarlagt.
English: If you vomit less than 1 hour after taking Emtricitabine/Tenofovir disoproxil Krka d.d., take another tablet.
Danish: Hvis De kaster op mindre end en time efter, De har taget Emtricitabine/Tenofovir disoproxil Krka d.d., skal De tage en ny tablet.
English: Renally eliminated medicinal products: Since emtricitabine and tenofovir are primarily eliminated by the kidneys, co-administration of Emtricitabine/Tenofovir disoproxil Krka d.d.
Danish: Lægemidler, som udskilles gennem nyrerne: Da emtricitabin og tenofovir primært udskilles gennem nyrerne, kan administration af Emtricitabine/Tenofovir disoproxil Krka d.d.
English: If serum phosphate is < 1.5 mg/dL (0.48 mmol/L) or creatinine clearance is decreased to < 50 mL/min in any patient receiving Emtricitabine/Tenofovir disoproxil Krka d.d., renal function should be reevaluated within one week, including measurements of blood glucose, blood potassium and urine glucose concentrations (see section 4.8, proximal tubulopathy).
Danish: Håndtering af nedsat nyrefunktion hos HIV 1-inficerede patienter Hvis serumphosphat er < 1,5 mg/dl (0,48 mmol/L), eller kreatininclearance er reduceret til < 50 ml/min hos patienter, der får Emtricitabine/Tenofovir disoproxil Krka d.d., bør nyrefunktionen revurderes inden for en uge, herunder måling af blodglucose, blodkalium og uringlucose (se pkt.
English: Other effects in children Children given emtricitabine very commonly experienced changes in skin colour including darkening of the skin in patches Children commonly experienced low red blood cell count (anaemia).
Danish: Andre bivirkninger hos børn Hos børn, der får emtricitabin, er det meget almindeligt at opleve ændringer i hudfarven, herunder Pletvis mørkfarvning af huden Hos børn er det almindeligt at opleve et lavt antal røde blodlegemer (anæmi) Dette kan forårsage, at barnet blivet træt eller stakåndet → Hvis De bemærker nogen af disse symptomer, skal De fortælle det til lægen.
English: contains emtricitabine and tenofovir disoproxil, any interactions that have been identified with these agents individually may occur with Emtricitabine/Tenofovir disoproxil Krka d.d.. Interaction studies have only been performed in adults.
Danish: Emtricitabine/Tenofovir disoproxil Krka d.d.. Interaktionsstudier er kun udført hos voksne.
English: The mean (%CV) tenofovir drug exposure increased from 2,185 (12%) ng•h/mL in subjects with normal renal function, to 3,064 (30%) ng•h/mL, 6,009 (42%) ng•h/mL and 15,985 (45%) ng•h/mL, in subjects with mild, moderate and severe renal impairment, respectively.
Danish: Den gennemsnitlige (% variationskoefficient) tenofovireksponering steg fra 2.185 (12%) ng•t/mL hos forsøgspersoner med normal nyrefunktion til 3.064 (30%) ng•t/mL, 6.009 (42%) ng•t/mL og 15.985 (45%) ng•t/mL hos forsøgspersoner med henholdsvis let, moderat og svært nedsat nyrefunktion.
English: 2 to 15 years) were exposed to tenofovir disoproxil for a median of 331 weeks.
Danish: 4 af disse seponerede behandlingen med tenofovirdisoproxil (median eksponering for tenofovirdisoproxil var 331 uger).
English: HIV-1 infected patients receiving Emtricitabine/Tenofovir disoproxil Krka d.d.
Danish: Hiv 1-inficerede patienter, som får Emtricitabine/Tenofovir disoproxil Krka d.d.
English: Consideration should be given to interrupting treatment with Emtricitabine/Tenofovir disoproxil Krka d.d.
Danish: Det bør overvejes at afbryde behandlingen med Emtricitabine/Tenofovir disoproxil Krka d.d.